Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01812226 · ClinicalTrials.gov registry record
Alcohol Biomarkers in Post-Liver Transplant Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 214
- Enrollment target
NCT01812226 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 214 participants.
The verdict
NCT01812226 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 214 participants
- Enrollment target
Study Summary
The aim of this study is to compare the predictive validity and reliability of PEth testing at detecting alcohol use in post liver transplant patients. A prospective cohort study will be used to test the primary hypothesis. Subjects enrolled in the study will be followed for 12 months with biomarker levels drawn at baseline, six and 12 months. The baseline interview will inquire about the previous 30 day alcohol and tobacco use; lifetime and 12 month Diagnostic and Statistical Manual-IV criteria for alcohol abuse and/or dependence; prior alcohol treatment; history of abstinence prior to transplant; co-morbid medical issues; and depression. The six and 12 months interview will focus on previous 30 day alcohol use. The baseline, six and 12 months interviews will be conducted face-to-face at each site. While many patients who receive a transplant do not live near the academic medical center that performed the surgery patient, they normally have a transplant clinic visit 1-2 times per year. Medical records and transplant databases will be assessed to assess the other variables of interest.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01812226
The ClinicalTrials.gov registry entry for NCT01812226 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01812226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01812226 about?
NCT01812226 is a clinical study titled "Alcohol Biomarkers in Post-Liver Transplant Patients". The aim of this study is to compare the predictive validity and reliability of PEth testing at detecting alcohol use in post liver transplant patients. A prospective cohort study will be used to test the primary hypothesis. Subjects enrolled in the study will be followed for 12 months with biomarker...
What is the current status of trial NCT01812226?
This trial is currently completed. The enrollment target is 214 participants. The study started on 2013-03. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01812226?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.